drugset / Trial / NCT00245674

SOLIACS: Solian Solution in the Acute Setting

NCT00245674

Phase 4 Completed 300 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

During this study the efficacy and safety profile will be evaluated of the use of amisulpride in the form of a solution in schizophrenic patients with an acute episode. The main purpose of the study is to observe the anti-psychotic effect of amisulpride as a solution during the first days of an acute episode of schizophrenia.

Timeline

Start
2005-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule

Indications